Eagle Pharmaceuticals, Inc. Lease, Cost
Eagle Pharmaceuticals, Inc. reported Lease, Cost of $845.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2023-08-09
- Eagle Pharmaceuticals, Inc. lease, cost for the quarter ending 2023-06-30 was $424.00K, a 10.13% increase year-over-year.
- Eagle Pharmaceuticals, Inc. lease, cost for the quarter ending 2023-03-31 was $421.00K, a 12.27% increase year-over-year.
- Eagle Pharmaceuticals, Inc. lease, cost for the quarter ending 2022-12-31 was $334.00K.
- Eagle Pharmaceuticals, Inc. lease, cost for the quarter ending 2022-09-30 was $413.00K.
- Eagle Pharmaceuticals, Inc. lease, cost for fiscal 2021 was $1.41M, a 6.35% increase from fiscal 2020.
- Eagle Pharmaceuticals, Inc. lease, cost for fiscal 2020 was $1.32M, a 15.45% increase from fiscal 2019.
- Eagle Pharmaceuticals, Inc. lease, cost for fiscal 2019 was $1.15M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-06-30 | $424.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-08-09 | $845.00K 10-Q/A · filed 2023-08-09 | $1.18M derived: sum of 3 quarters · filed 2023-08-09 | $1.59M derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | $421.00K 10-Q · filed 2023-05-09 | $755.00K derived: sum of 2 quarters · filed 2023-08-09 | $1.17M derived: sum of 3 quarters · filed 2023-08-09 | $1.55M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-12-31 | $334.00K derived: 10-Q/A 12 month − 10-Q 9 month · filed 2023-08-09 | $747.00K derived: sum of 2 quarters · filed 2023-08-09 | $1.13M derived: sum of 3 quarters · filed 2023-08-09 | $1.51M 10-Q/A · filed 2023-08-09 |
| 2022-09-30 | $413.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $798.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.17M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $385.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $760.00K 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | $375.00K 10-Q · filed 2022-05-09 | |||
| 2021-12-31 | $1.41M 10-K · filed 2023-03-23 | |||
| 2021-03-31 | $343.00K 10-Q · filed 2021-05-10 | |||
| 2020-12-31 | $1.32M 10-K · filed 2022-03-08 | |||
| 2019-12-31 | $1.15M 10-K · filed 2021-03-05 |